AOD 9604 / MOTs-C / Tesamorelin / Ipamorelin
Four-peptide fat loss and repair blend.
A compounded four-peptide blend combining AOD 9604 (targeted lipolysis), MOTs-C (mitochondrial-derived metabolic regulation and insulin sensitivity), Tesamorelin (visceral adipose reduction via GHRH signaling), and Ipamorelin (clean endogenous GH pulse). Together these address fat loss from multiple mechanisms at once — adipocyte breakdown, mitochondrial energy handling, visceral fat mobilization, and growth-hormone-mediated recovery — in a single injection for patients pursuing aggressive body-recomposition alongside tissue and joint repair.
Clinical indications
- Multi-pathway fat loss
- Visceral fat reduction
- Improved energy output
- Joint & tissue repair
Nightly subcutaneous injection, 5 days on / 2 off, 12–16 weeks
Suggested reference only. Final dosing is set by the prescribing clinician in our independent third-party network.